OrbiMed targets $1.2bn for new credit vehicle

The healthcare-focused lender provides both debt and equity strategies to life science companies worldwide.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this